Abstract:Introduction Cannabis consumption constitutes a public health problem both because of its serious repercussions and complications and the psychological and social problems it causes. Objectives Our objective was to assess the level of cannabis dependence in consumers receiving care at the Sfax detoxification center in Tunisia, to describe the sociodemographic profile of these consumers and the neuropsychological complications that may be caused. Methods We conducted a cross-sectional study, over a period of 13 months (September 2020 to October 2021), among cannabis users consulting the Sfax detoxification center in Tunisia. We used the Cannabis Abuse Screening Test (CAST) in order to detect a "problematic" cannabis use, along with a clinical information sheet to collect epidemiological and clinical data. All patients gave their free and informed oral consent to participate in the survey while ensuring anonymity. Results We included 38 patients. The average age was 26 years old with a median age of starting cannabis use at 17 years old. The sex ratio was 8.5 with an over-representation of men. Most of the subjects were single, lived with their family and had a secondary school education. Consumption was daily for the majority of patients (68.5%) with an average quantity of 4 joints/day. According to the CAST scale, 36 users (94.7%) had problematic cannabis use. The factors favouring cannabis consumption were stress and anxiety in 34 patients (89.5%) followed by depression and the festive atmosphere in 14 subjects (36.8%) each. Among the participants, 26.3% had a psychiatric history including depression (5.3%), a psychopathic personality disorder (10.5%) and cannabis-induced psychotic disorder (10.5%). History of psychiatric hospitalization and history of suicide attempt were found in 21.1% and 26.3% of the patients respectively. Concerning the complications caused by cannabis, 68.4% of the patients described a phenomenon of tolerance, while 63.2% reported the sensation of craving. Psychotic symptoms such as delirium and/or hallucinations were found in 6 patients (15.8%) and 8 subjects (21.1%) reported a history of overdose in the form of cannabis psychosis. Chronic complications were an amotivational syndrome (63.2%) and social disintegration (52.6%). Treatment of cannabis dependence was considered effective with total withdrawal in 31.6% of subjects. Weaning was partial in 42.1% of the patients. Conclusions Cannabis use is emerging as one among many interacting factors that can affect psychological and physical health, with an impact on various levels including mood, neurocognition and general health. Although studies have shown functional brain mechanisms underlying the effects of cannabis, the exact mechanisms remain unclear. Overall, treatment for substance use disorders generally prevents these complications and improves prognosis. Disclosure of Interest None Declared

[Prevalence of cannabis and tobacco use in patients attending a methadone center. Evaluation by urinary biomarkers]

Trends in polysubstance use among patients in methadone maintenance treatment in Ireland: Evidence from urine drug testing 2010-2020

Direct-To-Definitive Urine and Oral Fluid Test Results for Unscreened and Rarely Screened Drugs in Individuals Applying for Methadone Treatment in 7 U.S. States

Tobacco and Alcohol Use among Drug Users Receiving Methadone Maintenance Treatment: A Cross-Sectional Study in A Rural Prefecture of Yunnan Province, Southwest China

Sociodemographic and clinical characteristics of patients on Methadone followed at Ar Razi hospital in Morocco

Evaluation of urinary trace element levels in patients with opioid use disorder undergoing methadone treatment in western Iran

On the Value of Measuring Recent Drug Use by Self-Reports and Urinalysis in Clinical Trials

Fentanyl abuse proportion in methadone maintenance treatment, and patients’ knowledge about its risks

Evaluation of Complete Blood Cell Count Parameters and Their Role in Inflammation in Patients with Methamphetamine and Synthetic Cannabis Use Disorder

Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs

Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Predicting Time to Return to Cannabis Use After a Cessation Attempt: Impact of Cumulated Exposure to Nicotine-Containing Products

Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada

Comparative analysis of addiction severity index in methadone maintenance treatment: impact of concurrent methamphetamine use among patients in Rasht, Iran 2022–2023

Cannabis addiction in Tunisia: sociodemographic profile and neuropsychological complications

High Prevalence Of Hiv, Hcv And Tuberculosis And Associated Risk Behaviours Among New Entrants Of Methadone Maintenance Treatment Clinics In Guangdong Province, China

Modulation of Attentional Bias to Drug and Affective Cues by Therapeutic and Neuropsychological Factors in Patients With Opioid Use Disorder on Methadone Maintenance Therapy

PET Imaging of Dopamine Transporter and Drug Craving During Methadone Maintenance Treatment and after Prolonged Abstinence in Heroin Users.

Socio-demographic and clinical profile of opoid users

Characterization of cannabis withdrawal symptoms and serum levels of neurotransmitters among cannabis-dependent smokers during sustained abstinence within a controlled residential environment

Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study